Not recommended for all those living in a highly endemic area like Uganda. However, it is recommended for certain high-risk groups but is not 100% effective.
PATIENT GROUPPROPHYLAXIS
Pregnancy
In endemic areas,
pregnant women
carry malaria
parasites in their
blood or placenta,
which is harmful to
the health of both
mother and foetus |
- Give intermittent preventive
treatment (IPT) to ensure the
well-being of mother and foetus
- SP single dose (3 tabs) given at
13 weeks and continued monthly
until delivery
- Ensure doses are taken under
supervision by the health
provider as directly observed
therapy (DOT)
- Record doses on the patient’s
card and treatment register and
summarise further in the delivery
book and monthly returns
- Do not give SP in HIV patients on
cotrimoxazole
|
Sicke cell disease |
- Chloroquine
Adult: 300 mg base weekly
Child: 5 mg (base)/kg weekly
- or Sulphadoxinepyrimethamine
(SP)
|
People living
with HIV |
- Cotrimoxazole daily as per
national guidelines
|
Non-immune
visitors/tourists |
- Mefloquine
Adult: 250 mg once weekly
Child: 5 mg/kg once weekly
|